The Journal of Organic Chemistry
Page 4 of 6
m/z: [M + H]+ Calcd for C14H20NO2 234.1494; Found C14H20NO2
EXPERIMENTAL SECTION.
234.1502.
1
2
3
4
5
6
7
8
General Considerations: All manipulations were carried out
using standard Schlenk techniques and a dry-box. CDCl3 and
CD2Cl2 were distilled over CaH2. Catalytic system 1 has been pre-
pared and used according to a published report.10 All other chemi-
cals were purchased from commercial sources and used without
further purification. NMR spectra were received using Bruker AV
300 or JEOL ECA400 SL spectrometers. Mass spectrometry was
performed by Waters Q-Tof Premier Micromass instrument, using
the electrospray ionization (ESI) mode.
3-(methyl(4-(3-oxobutyl)phenyl)amino)propanenitrile (4f): 140
mg, 61%. 1H NMR (300 MHz, CDCl3) δ 7.08 (d, J = 4.8 Hz, 2H),
6.85 (d, J = 4.8 Hz, 2H), 3.69(t, J = 5.52 Hz, 2H), 2.98 (s, 3H), 2.82
- 2.80 (m, 2H), 2.79 - 2.68 (m, 2H), 2.56 (t, J = 5.52 Hz, 2H), 2.13
(s, 3H). 13C NMR (75 MHz, CDCl3) δ 208.4, 146.1, 130.2, 129.4,
118.6, 113.0, 49.2, 45.5, 38.8, 30.1, 28.8, 15.2. HRMS (ESI-TOF)
m/z: [M + H]+ Calcd for C14H19N2O 231.1497; Found 231.1495.
4-(1-methyl-1,2,3,4-tetrahydroquinolin-6-yl)butan-2-one (4g): 200
mg, 92%. 1H NMR (300 MHz, CDCl3) δ 6.87 (d, J = 6.2 Hz, 1H),
6.78 (m, 1H), 6.53 (d, J = 6.2 Hz, 1H), 3.19 - 3.16 (m, 2H), 2.85 (s,
3H), 2.75 - 2.70 (m, 6H), 2.13 (s, 3H), 1.98-1.95 (m, 2H). 13C NMR
(75 MHz, CDCl3) δ 208.7, 145.3, 128.9, 128.5, 126.7, 123.1, 111.3,
51.4, 45.8. 39.3, 30.1, 28.9, 27.8, 22.6. HRMS (ESI-TOF) m/z: [M
+ H]+ Calcd for C14H20NO 218.1545; Found 218.1544.
9
General Procedures - Coupling reaction of aromatic and hetro-
aromatic compounds with α, β-unsaturated carbonyl-containing
compounds: 1 (formed by mixing its components DipLal(OTf)2 (19
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
mg, 0.025 mmol, 2.5 mol%) and NaBArCl (16 mg, 0.025 mmol,
4
2.5 mol%) was dissolved dissolved in 1.5 mL CD2Cl2 in a J. Young
NMR tube. Subsequently 1 equiv of the α,β-unsaturated carbonyl-
containing compounds (1.0 mmol) and 2 equiv of the aromatic or
hetro-aromatic compounds (2.0 mmol) were added. The reaction
mixture was left for the time indicated in Table 1 and Scheme 2 - 3
in the main text. After reaction completion, the corresponding prod-
ucts were purified by flash column chromatography on silica gel
using hexane/ethyl acetate mixtures. The formation of 4a and 4n
was also achieved by reacting 1.0g (8.2 mmol) of 2a and 1.07 g
(8.2 mmol) of 2n, respectively, with 0.29g (4.1 mmol) of 3a in the
presence of 78 mg (0.10 mmol) of DipLal(OTf)2 and 66 mg (0.10
mmol) of NaBArCl4 in about 10 ml of CH2Cl2 for 1h at room tem-
perature. These products were also isolated by the established pro-
cedure.
4-(2,3,6,7-tetrahydro-1H,5H-pyrido[3,2,1-ij]quinolin-9-yl)butan-
2-one (4h): 231 mg, 95%. H NMR (300 MHz, CDCl3) δ 6.61 (s,
2H), 3.11 - 3.07 (m, 4H), 2.75 - 2.70 (m, 8H), 2.15 (s, 3H), 2.00 -
1.92 (m, 4H). 13C NMR (75 MHz, CDCl3) δ 208.6, 141.3, 128.1,
126.7, 121.8, 50.1, 45.8, 30.0, 28.9, 27.5, 22.2. HRMS (ESI-TOF)
m/z: [M + H]+ Calcd for C16H22NO 244.1701; Found 244.1699.
1
4-(4-(dimethylamino)-2-methylphenyl)butan-2-one (4i): 195 mg,
1
95%. H NMR (300 MHz, CDCl3) δ 7.00 - 6.97 (m, 1H), 6.56 -
6.53 (m, 2H), 2.90 (s, 6H), 2.80 - 2.77 (m, 2H), 2.68 - 2.66 (m, 2H),
2.28 (s, 3H), 2.14 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 208.6,
149.4, 136.4, 129.3, 127.3, 114.9, 110.8, 44.5, 40.8, 30.0, 26.3,
19.8. HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C13H20NO
206.1545; Found 206.1548.
Characterization of the synthesized compounds:
4-(4-(dimethylamino)phenyl)butan-2-one (4a): 185 mg, 97% (for
4-(4-(dimethylamino)-2-methoxyphenyl)butan-2-one (4j): 222 mg,
the NMR scale reaction) and 760 mg, 97% (for the gram scale re-
1
96%. H NMR (300 MHz, CDCl3) δ 6.98 - 6.95 (m, 1H), 6.26 -
1
action). H NMR (300 MHz, CDCl3) δ 7.06 (d, J = 8.6 Hz, 2H),
6.24 (m, 2H), 3.82 (s, 3H), 2.92 (s, 6H), 2.70 - 2.75 (m, 2H), 2.73 -
2.67 (m, 2H), 2.13 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 209.3,
158.1, 150.8, 130.2, 117.5, 104.8, 96.5, 55.0, 44.3, 40.9, 29.9, 24.3.
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C13H20NO2 222.1494;
Found 222.1499.
6.70 (d, J = 8.6 Hz, 2H), 2.91 (s, 6H), 2.88 - 2.77 (m, 2H), 2.76 -
2.65 (m, 2H), 2.13 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 208.7,
149.2, 129.0, 128.9, 113.2, 45.7, 41.0, 30.2, 28.9. HRMS (ESI-
TOF) m/z: [M + H]+ Calcd for C12H18NO 192.1388; Found
192.1382.
4-(4-(diethylamino)phenyl)butan-2-one (4b): 215 mg, 98%. 1H
NMR (300 MHz, CDCl3) δ 7.04 (d, J = 6.8 Hz, 2H), 6.64 (d, J =
6.8 Hz, 2H), 3.35 (q, J = 5.6 Hz, 4H), 2.81 - 2.77 (m, 2H), 2.76 -
2.65 (m, 2H), 2.14(s, 3H), 1.16 (t, J = 5.6 Hz, 6H). 13C NMR (75
MHz, CDCl3) δ 208.7, 146.3, 129.0, 127.6, 112.2, 45.7, 44.4, 30.1,
28.8, 12.6. HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C14H22NO
220.1701; Found 220.1721.
4-(2-bromo-4-(dimethylamino)phenyl)butan-2-one (4k): 259 mg,
96%. 1H NMR (300 MHz, CDCl3) δ 7.07 (d, J = 8.5 Hz, 1H), 6.87
(d, J = 2.6 Hz, 1H), 6.60 (dd, J = 8.5, 2.7 Hz, 1H), 2.92 (m, 8H),
2.73 (m, 2H), 2.13 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 208.2,
150.1, 130.6, 127.3, 124.9, 116.3, 111.9, 44.0, 40.5, 30.0, 29.3.
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C12H17NOBr 270.0494;
Found 270.0506.
4-(4-(dimethylamino)naphthalen-1-yl)butan-2-one (4m): 227 mg,
1
4-(4-(dibenzylamino)phenyl)butan-2-one (4c): 336 mg, 98%. H
1
94%. H NMR (300 MHz, CDCl3) δ 8.31 - 8.29 (m, 1H), 7.96 -
NMR (300 MHz, CDCl3) δ 7.40 - 7.23 (m, 10H), 6.99 (m, 2H), 6.67
(m, 2H), 4.62 (s, 4H), 2.91 (s, 6H), 2.80 - 2.76 (m, 2H), 2.75 - 2.65
(m, 2H), 2.12 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 208.6, 147.7,
138.1, 129.0, 128.9, 128.7, 126.9, 126.7, 112.7, 54.4, 45.6, 30.1,
28.9. HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C24H26NO
344.2014; Found 344.2012.
7.94 (m, 1H), 7.51 -7.49 (m, 2H), 7.25 - 7.23 (m, 1H), 7.01 (d, J =
5.9 Hz, 1H), 3.31 - 3.27 (m, 2H), 2.90 m,8H), 2.16 (s, 3H).13C
NMR (75 MHz, CDCl3) δ 208.3, 149.9, 132.7, 131.5, 129.3, 125.9,
125.0, 124.9, 123.9, 113.8, 45.4, 44.6, 30.1, 26.6. HRMS (ESI-
TOF) m/z: [M + H]+ Calcd for C16H20NO 242.1545; Found
242.1544.
1
4-(4-(pyrrolidin-1-yl)phenyl)butan-2-one (4d): 204 mg, 94%. H
4-(1-methyl-1H-indol-3-yl)butan-2-one (4n): 187 mg, 93% (for the
NMR scale reaction) and 780 mg, 95% (for the gram scale reac-
tion). 1H NMR (300 MHz, CDCl3) δ 7.65 - 7.62 (m, 1H), 7.33-7.21
(m, 2H), 7.17 - 7.16 (m, 1H), 6.88 (s, 1H), 3.76 (s, 3H), 3.10 - 3.07
(m, 2H), 2.89 - 2.86 (m, 2H), 2.18 (s, 3H). 13C NMR (75 MHz,
CDCl3) δ 208.8, 137.0, 127.5, 126.4, 121.6, 118.7, 118.7, 113.6,
109.2, 44.3, 32.5, 30.0, 19.2. HRMS (ESI-TOF) m/z: [M + H]+
Calcd for C13H16NO 202.1232; Found 202.1225.
4-(5-methylfuran-2-yl)butan-2-one (4o):143 mg, 94%. 1H NMR
(300 MHz, CDCl3) δ 5.85 - 5.82 (m, 2H), 2.85 - 2.83 (m, 2H), 2.77
- 2.75 (m, 2H), 2.23 (s, 3H), 2.15 (s, 3H). 13C NMR (75 MHz,
CDCl3) δ 207.5, 152.7, 150.6, 105.9, 105.8, 42.0, 29.9, 22.3, 13.5.
NMR (300 MHz, CDCl3) δ 7.05 (d, J = 6.51 Hz, 2H), 6.51 (d, J =
6.51 Hz, 2H), 3.39 - 3.23 (m, 4H), 2.80 - 2.78 (m, 2H), 2.72 - 2.70
(m, 2H), 2.13 (s, 3H), 2.00 - 1.97 (m, 4H). 13C NMR (75 MHz,
CDCl3) δ 208.7, 146.7, 129.0, 127.5, 111.8, 47.8, 45.9, 30.2, 29.0,
25.5. HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C14H21NO
218.1545; Found 218.1548.
4-(4-morpholinophenyl)butan-2-one (4e): 214 mg, 92%. 1H NMR
(300 MHz, CDCl3) δ 7.10 - 7.08 (m, 2H), 6.85 - 6.83 (m, 2H), 3.83
- 3.86 (m, 4H), 3.12 - 3.10 (m, 4H), 2.84 - 2.80 (m, 2H), 2.73 - 2.69
(m, 2H), 2.13 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 208.3, 149.7,
132.6, 129.0, 116.0, 67.0, 49.7, 45.4, 30.2, 28.9. HRMS (ESI-TOF)
ACS Paragon Plus Environment